Carol Astbury

704 total citations
38 papers, 527 citations indexed

About

Carol Astbury is a scholar working on Rheumatology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carol Astbury has authored 38 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 15 papers in Physiology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carol Astbury's work include Asthma and respiratory diseases (13 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Carol Astbury is often cited by papers focused on Asthma and respiratory diseases (13 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Carol Astbury collaborates with scholars based in United Kingdom, Spain and United States. Carol Astbury's co-authors include H. A. Bird, Jacqueline Hill, Simon P. Robins, A. J. Taggart, V Wright, Vera Neumann, Jonathan S. Dixon, H. A. Bird, Beatriz Seoane and J. S. Dixon and has published in prestigious journals such as Annals of the Rheumatic Diseases, European Respiratory Journal and Drugs.

In The Last Decade

Carol Astbury

35 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Astbury United Kingdom 13 210 90 82 81 77 38 527
William H. Vaughn United States 12 435 2.1× 27 0.3× 179 2.2× 61 0.8× 44 0.6× 16 856
Taiji Sawamoto Japan 17 99 0.5× 60 0.7× 100 1.2× 18 0.2× 27 0.4× 30 644
T. J. Daymond United Kingdom 10 107 0.5× 145 1.6× 29 0.4× 40 0.5× 31 0.4× 14 355
Celia María Quiñonez-Flores Mexico 9 232 1.1× 23 0.3× 171 2.1× 24 0.3× 96 1.2× 20 513
Mahta Mazaheri Iran 19 68 0.3× 46 0.5× 195 2.4× 21 0.3× 82 1.1× 65 735
Leon van Haandel United States 16 126 0.6× 71 0.8× 115 1.4× 16 0.2× 42 0.5× 35 609
Ling Meng China 13 197 0.9× 41 0.5× 106 1.3× 46 0.6× 68 0.9× 34 592
Lukas Haragsim United States 9 27 0.1× 46 0.5× 166 2.0× 52 0.6× 43 0.6× 19 542
Reisuke Saito United States 14 70 0.3× 132 1.5× 153 1.9× 57 0.7× 34 0.4× 27 675
Toshio Yamamoto Japan 14 53 0.3× 19 0.2× 128 1.6× 46 0.6× 17 0.2× 43 545

Countries citing papers authored by Carol Astbury

Since Specialization
Citations

This map shows the geographic impact of Carol Astbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Astbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Astbury more than expected).

Fields of papers citing papers by Carol Astbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Astbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Astbury. The network helps show where Carol Astbury may publish in the future.

Co-authorship network of co-authors of Carol Astbury

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Astbury. A scholar is included among the top collaborators of Carol Astbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Astbury. Carol Astbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambery, Phil, Grzegorz Zając, J.O. Almquist, et al.. (2024). The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial. British Journal of Clinical Pharmacology. 90(8). 1921–1931. 1 indexed citations
2.
Laar, Jacob M. van, J.O. Almquist, Graham Belfield, et al.. (2023). AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study. Clinical and Translational Science. 16(12). 2494–2506. 7 indexed citations
3.
Ambery, Phil, Samuel Adamsson Eryd, Sara Jenkins‐Jones, et al.. (2022). The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid‐related and phenotypic groups. Diabetes Obesity and Metabolism. 24(11). 2222–2231. 5 indexed citations
4.
Singh, Dave, Jutta Beier, Carol Astbury, et al.. (2021). The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD. European Respiratory Journal. 59(4). 2100972–2100972. 11 indexed citations
5.
6.
7.
8.
9.
Beier, Jutta, et al.. (2013). Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study. European Respiratory Journal. 42(Suppl 57). 183–183. 6 indexed citations
10.
Beyeler, C, et al.. (1996). Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs.. Annals of the Rheumatic Diseases. 55(7). 478–481. 1 indexed citations
11.
Astbury, Carol, et al.. (1994). A clinical and biochemical assessment of methotrexate in rheumatoid arthritis. Clinical Rheumatology. 13(1). 75–79. 15 indexed citations
12.
Astbury, Carol, et al.. (1993). OPTIMIZING THE ASSESSMENT OF DISEASE ACTIVITY DURING TREATMENT WITH ANTI-RHEUMATOID DRUGS. Lara D. Veeken. 32(6). 467–473. 8 indexed citations
13.
Astbury, Carol, Jennie L. Hill, & H. A. Bird. (1992). PHTHALYLSULPHATHIAZOLE IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 31(7). 461–463. 4 indexed citations
14.
Smith, John A., et al.. (1991). Human nocturnal blood melatonin and liver acetylation status. Journal of Pineal Research. 10(1). 14–17. 3 indexed citations
15.
Astbury, Carol, et al.. (1990). METHYLSULPHASALAZINE IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 29(6). 465–467. 2 indexed citations
16.
Astbury, Carol. (1988). A modified reversed-phase high-performance liquid chromatographic method for the determination of plasma sulphasalazine concentrations. Journal of Pharmaceutical and Biomedical Analysis. 6(1). 103–107. 7 indexed citations
17.
Astbury, Carol, et al.. (1986). A parallel group comparison of tenoxicam and piroxicam in patients with ankylosing spondylitis.. PubMed. 4(7). 457–62. 15 indexed citations
18.
Robins, Simon P., et al.. (1986). Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.. Annals of the Rheumatic Diseases. 45(12). 969–973. 90 indexed citations
19.
Taggart, A. J., Carol Astbury, Jonathan S. Dixon, & H. A. Bird. (1986). Prednisolone pharmacokinetics in patients with rheumatoid arthritis, polymyalgia rheumatica and asthma. Clinical Rheumatology. 5(3). 327–331. 4 indexed citations
20.
Bird, H. A., et al.. (1985). A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis.. Annals of the Rheumatic Diseases. 44(3). 189–193. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William H. Vaughn Breakdown of academic impact, for papers by Taiji Sawamoto Breakdown of academic impact, for papers by T. J. Daymond Breakdown of academic impact, for papers by Celia María Quiñonez-Flores Breakdown of academic impact, for papers by Mahta Mazaheri Breakdown of academic impact, for papers by Leon van Haandel Breakdown of academic impact, for papers by Ling Meng Breakdown of academic impact, for papers by Lukas Haragsim Breakdown of academic impact, for papers by Reisuke Saito Breakdown of academic impact, for papers by Toshio Yamamoto
Rankless by CCL
2026